Alrizomadlin
Product Specifications
CAS Number
1818393-16-6
Target
MDM-2/p53|||E1/E2/E3 Enzyme|||Mdm2|||Apoptosis
Related Pathways
Apoptosis|||Ubiquitination
Purity
0.9947
Bioactivity
Alrizomadlin is an orally active MDM2 inhibitor. APG-115 shows significant dose-dependent inhibitory effects on TP53wt AML cell lines. The IC50 values ??are 26.8 nM for MOLM-13 cells and 165.9 nM for MV-4-11 cells. , OCI-AML-3 cells 315.6 nM. Alrizomadlin blocks the interaction of MDM2 and p53 and induces cell cycle arrest and apoptosis in a p53-dependent manner.
Smiles
CCN1[C@H]([C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc23)C11CCCCC1)C(=O)NC12CCC(CC1)(CC2)C(O)=O
Molecular Formula
C34H38Cl2FN3O4
Molecular Weight
642.59
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
126211-FITC 100 µL
EHD4 (EH Domain-containing Protein 4, Hepatocellular Carcinoma-associated Protein 10/11, PAST Homolog 4, HCA10, HCA11, PAST4, FKSG7) (FITC)
Ask
View Details 148782 100 µg
RAB8A, Control Peptide (Oncogene c-mel, Ras-related Protein Rab-8A, MEL, RAB8)
Ask
View Details 